Literature DB >> 15864238

Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.

Charles R Kerr1, Karin H Humphries, Mario Talajic, George J Klein, Stuart J Connolly, Martin Green, John Boone, Robert Sheldon, Paul Dorian, David Newman.   

Abstract

BACKGROUND: After its initial diagnosis, atrial fibrillation (AF) may progress from paroxysmal to chronic AF (CAF). The rate of progression and risk factors for progression are not clearly defined.
METHODS: The Canadian Registry of Atrial Fibrillation (CARAF) enrolled patients from 6 Canadian cities at the time of their first electrocardiographic diagnosis of AF. Comprehensive clinical and echocardiographic data were collected and patients were followed annually, carefully documenting clinical outcomes, recurrence of paroxysmal AF, and progression to CAF. Baseline clinical, electrocardiographic, and echocardiographic variables were evaluated by univariate Cox proportionate hazards analysis. A stepwise approach was used to model the association between echocardiographic and clinical variables with progression to CAF.
RESULTS: A total of 757 patients with a baseline diagnosis of paroxysmal AF were evaluated. Median follow-up was 8.0 years (range 2 days to 11.1 years). The probability of progression to CAF by 1 year was 8.6% and thereafter there was a slow but steady progression to 24.7% by 5 years. By 5 years, the probability of documented recurrence of any AF (chronic or paroxysmal) was 63.2%. Increasing age, significant aortic stenosis or mitral regurgitation, left atrial enlargement, and diagnosis of cardiomyopathy were independently associated with progression to CAF. A more rapid heart rate during AF was associated with decreased risk of progression.
CONCLUSIONS: After the initial diagnosis of paroxysmal AF, there is a slow but steady progression to CAF. Baseline echocardiographic variables, age, cardiomyopathy, and heart rate were independently associated with progression to CAF.

Entities:  

Mesh:

Year:  2005        PMID: 15864238     DOI: 10.1016/j.ahj.2004.09.053

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  79 in total

Review 1.  Atrial remodeling, fibrosis, and atrial fibrillation.

Authors:  José Jalife; Kuljeet Kaur
Journal:  Trends Cardiovasc Med       Date:  2014-12-31       Impact factor: 6.677

Review 2.  Contemporary management of atrial fibrillation: update on anticoagulation and invasive management strategies.

Authors:  Mark A Crandall; David J Bradley; Douglas L Packer; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

Review 3.  Novel pharmacological targets for the rhythm control management of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2011-08-17       Impact factor: 12.310

Review 4.  Atrial Fibrillation Progression: New Insight in TheNatural History of This Arrhythmia.

Authors:  Sanjay Dixit
Journal:  J Atr Fibrillation       Date:  2009-02-01

Review 5.  Invasive Management of Atrial Fibrillation and the Elderly.

Authors:  Sandeep M Patel; Samuel J Asirvatham
Journal:  J Atr Fibrillation       Date:  2010-08-23

6.  Relation of gender and interatrial dyssynchrony on tissue Doppler imaging to the prediction of the progression to chronic atrial fibrillation in patients with nonvalvular paroxysmal atrial fibrillation.

Authors:  Koichi Sakabe; Nobuo Fukuda; Yamato Fukuda; Satofumi Morishita; Hisanori Shinohara; Yoshiyuki Tamura
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

Review 7.  Should Ablation Be First-Line Therapy for Patients with Paroxysmal AF?

Authors:  Sergio Conti; Atul Verma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

8.  Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation.

Authors:  Raphael P Martins; Kuljeet Kaur; Elliot Hwang; Rafael J Ramirez; B Cicero Willis; David Filgueiras-Rama; Steven R Ennis; Yoshio Takemoto; Daniela Ponce-Balbuena; Manuel Zarzoso; Ryan P O'Connell; Hassan Musa; Guadalupe Guerrero-Serna; Uma Mahesh R Avula; Michael F Swartz; Sandesh Bhushal; Makarand Deo; Sandeep V Pandit; Omer Berenfeld; José Jalife
Journal:  Circulation       Date:  2014-01-24       Impact factor: 29.690

9.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

10.  Evaluation of atrial fibrillation burden before catheter ablation predicts outcome after pulmonary vein isolation.

Authors:  Alexander Berkowitsch; Thomas Neumann; Malte Kuniss; Roland Brandt; Sergej Zaltsberg; Heinz F Pitschner
Journal:  Indian Pacing Electrophysiol J       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.